Profile
Michael S.
Eison worked as a Vice President in Regulatory Affairs and Research & Development at various pharmaceutical companies including Synosia Therapeutics, Stiefel Laboratories, and Connetics Corp.
He also worked as a Senior Director in Regulatory Affairs at InterMune, Inc. and as a Director in CNS Drug Discovery at Bristol Myers Squibb Co. Eison holds a doctorate degree from the University of California, Los Angeles and an undergraduate degree from The State University of New York.
Former positions of Michael S. Eison
| Companies | Position | End |
|---|---|---|
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | General Counsel | 14/04/2011 |
Synosia Therapeutics, Inc.
Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops products for unmet medical needs in psychiatry and neurology | Public Communications Contact | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| INTERMUNE INC | General Counsel | - |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
Training of Michael S. Eison
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Synosia Therapeutics AG
Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of psychiatry and neurology diseases | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synosia Therapeutics, Inc.
Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops products for unmet medical needs in psychiatry and neurology | Health Technology |
- Stock Market
- Insiders
- Michael S. Eison
















